Trial
NCT01449539
Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Arkansas
Collaborators
—
Condition
Multiple Myeloma
Intervention
Hyperbaric Oxygen Therapy
Why stopped
Study was terminated early because the site that administered the hyperbaric oxygen treatment closed and an alternative site could not be identified.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-02-23